Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalHepatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Fibroblast Growth Factor Receptors
Cholangiocarcinoma

ASJC Scopus subject areas

  • Hepatology

Cite this

@article{d21257844e4f40508fd5e3235e146792,
title = "Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened",
author = "Sumera Rizvi and Gores, {Gregory James}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/hep.30069",
language = "English (US)",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma

T2 - Looking Through a Door Half-Opened

AU - Rizvi, Sumera

AU - Gores, Gregory James

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85056322987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056322987&partnerID=8YFLogxK

U2 - 10.1002/hep.30069

DO - 10.1002/hep.30069

M3 - Article

C2 - 29704257

AN - SCOPUS:85056322987

JO - Hepatology

JF - Hepatology

SN - 0270-9139

ER -